Literature DB >> 18305955

Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.

C Protzel1, C Kakies, B Kleist, M Poetsch, J Giebel.   

Abstract

In penile squamous cell carcinoma (PSCC), the outcome largely depends on early detection and resection of inguinal lymph node metastases. We investigated the role of metastasis suppressor protein kang ai 1 (KAI1)/cluster of differentiation 82 (CD82), which is known to be of prognostic significance for a wide variety of cancers. Moreover, we analysed the tumours for human papillomavirus (HPV) DNA and loss of heterozygosity at the 11p11.2 locus. Tissue samples of 30 primary PSCCs were investigated immunohistochemically using an anti-KAI1/CD82 polyclonal antibody. The expression was assessed according to the degree of KAI1/CD82-positive tumour cells as positive, decreased or negative. The presence of HPV6/11, HPV16 and HPV18 DNA was analysed by polymerase chain reaction. All patients with decreased or negative expression of KAI1/CD82 in primary lesions had lymph node metastases (p = 0.0002). Patients with positive KAI1/CD82 expression showed a significant better prognosis for survival compared to the other groups (p = 0.0042). Presence of HPV DNA was associated with decreased or negative KAI1/CD82 expression. Lacking or decreased expression of metastasis suppressor gene KAI1/CD82 appears to be a prognostic parameter for the occurrence of lymph node metastases in PSCC. Our study suggests an association of decreased KAI1/CD82 expression with tumour progression, development of metastases and disease-specific death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305955     DOI: 10.1007/s00428-008-0590-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  44 in total

Review 1.  [Surgical therapy of penis carcinoma].

Authors:  C Doehn; M Baumgärtel; D Jocham
Journal:  Urologe A       Date:  2001-07       Impact factor: 0.639

2.  Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications.

Authors:  Birgit Gellersen; Juliane Briese; Marine Oberndörfer; Katja Redlin; Annemarie Samalecos; Dagmar-Ulrike Richter; Thomas Löning; Heinrich-Maria Schulte; Ana-Maria Bamberger
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.

Authors:  F S Liu; J T Dong; J T Chen; Y T Hsieh; E S Ho; M J Hung
Journal:  Gynecol Oncol       Date:  2000-07       Impact factor: 5.482

4.  Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.

Authors:  M Adachi; T Taki; Y Ieki; C L Huang; M Higashiyama; M Miyake
Journal:  Cancer Res       Date:  1996-04-15       Impact factor: 12.701

5.  KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma.

Authors:  F S Liu; J T Chen; J T Dong; Y T Hsieh; A J Lin; E S Ho; M J Hung; C H Lu
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

6.  Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma.

Authors:  Huachuan Zheng; Koichi Tsuneyama; Chunmei Cheng; Hiroyuki Takahashi; Zhengguo Cui; Kazuhiro Nomoto; Yoshihiro Murai; Yasuo Takano
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

7.  Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.

Authors:  Takayuki Takeda; Noboru Hattori; Takahiro Tokuhara; Yoshihiro Nishimura; Mitsuhiro Yokoyama; Masayuki Miyake
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.

Authors:  A Takaoka; Y Hinoda; S Satoh; Y Adachi; F Itoh; M Adachi; K Imai
Journal:  Oncogene       Date:  1998-03       Impact factor: 9.867

9.  p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.

Authors:  Ademar Lopes; Artur Licio R Bezerra; Clovis Antonio Lopes Pinto; Sergio Vicente Serrano; Celso Abdon de MellO; Luisa Lina Villa
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

10.  Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma.

Authors:  K Tagawa; K Arihiro; Y Takeshima; E Hiyama; M Yamasaki; K Inai
Journal:  Jpn J Cancer Res       Date:  1999-09
View more
  11 in total

Review 1.  Tetraspanins and tumor progression.

Authors:  Mekel M Richardson; Lisa K Jennings; Xin A Zhang
Journal:  Clin Exp Metastasis       Date:  2010-12-24       Impact factor: 5.150

Review 2.  Tetraspanins: push and pull in suppressing and promoting metastasis.

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

Review 3.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

4.  The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas.

Authors:  C Protzel; M Richter; M Poetsch; C Kakies; U Zimmermann; C Woenckhaus; K J Klebingat; O W Hakenberg; J Giebel
Journal:  World J Urol       Date:  2010-07-03       Impact factor: 4.226

5.  Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma.

Authors:  Chun Feng Lee; Zhi Qiang Ling; Ting Zhao; Shih Hua Fang; Weng Cheng Chang; San Chih Lee; Kuan Rong Lee
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

Review 6.  [Conventional grading vs. molecular grading : Decision aids for clinical routine].

Authors:  C Kakies; D Louise Dräger; P Spiess; O W Hakenberg; C Protzel
Journal:  Urologe A       Date:  2021-06-28       Impact factor: 0.639

7.  Normal viability of Kai1/Cd82 deficient mice.

Authors:  John I Risinger; Mary Custer; Lionel Feigenbaum; R Mark Simpson; Shelley B Hoover; Joshua D Webster; Gadisetti V R Chandramouli; Lino Tessarollo; J Carl Barrett
Journal:  Mol Carcinog       Date:  2013-02-08       Impact factor: 4.784

Review 8.  Molecular research in penile cancer-lessons learned from the past and bright horizons of the future?

Authors:  Chris Protzel; Philippe E Spiess
Journal:  Int J Mol Sci       Date:  2013-09-26       Impact factor: 5.923

9.  Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies.

Authors:  Jundong Zhu; Chenkui Miao; Shouyong Liu; Ye Tian; Chao Zhang; Chao Liang; Aiming Xu; Qiang Cao; Zengjun Wang
Journal:  Onco Targets Ther       Date:  2017-12-06       Impact factor: 4.147

10.  Assessment of TSPAN Expression Profile and Their Role in the VSCC Prognosis.

Authors:  Kelly Pedrozo Ferreira; Bruna Cristine de Almeida; Laura Gonzalez Dos Anjos; Glauco Baiocchi; Fernando Augusto Soares; Rafael Malagoli Rocha; Edmund Chada Baracat; Andrey Senos Dobroff; Katia Candido Carvalho
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.